Literature DB >> 21274387

Pernicious anemia: what are the actual diagnosis criteria?

Daniel Cattan.   

Abstract

A gastric intrinsic factor output under 200 U/h after pentagastrin stimulation (N > 2000 U/h) is specific for pernicious anemia. The other findings are either variable or non specific. Serum intrinsic factor antibodies, considered as specific in general practice, are present only in half of the patients with pernicious anemia. In their absence, since the disappearance of the Schilling tests, the gastric tubage currently used for the study of gastric acid secretion, is obligatory for the simultaneous study of intrinsic factor output. This study is important to eliminate another disease much more frequent than pernicious anemia, the protein bound to cobalamin malabsorption was observed in achlorhydric simple atrophic gastritis in the presence of intrinsic factor secretion.

Entities:  

Keywords:  Achlorhydria; Helicobacter pylori; Intrinsic factor; Pernicious anemia; Schilling test

Mesh:

Substances:

Year:  2011        PMID: 21274387      PMCID: PMC3027024          DOI: 10.3748/wjg.v17.i4.543

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  7 in total

1.  How I treat cobalamin (vitamin B12) deficiency.

Authors:  Ralph Carmel
Journal:  Blood       Date:  2008-07-07       Impact factor: 22.113

2.  Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis.

Authors:  Bruno Annibale; Edith Lahner; Riccardo Negrini; Flavia Baccini; Cesare Bordi; Bruno Monarca; Gianfranco Delle Fave
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

3.  Status of laboratory testing in the diagnosis of megaloblastic anemia.

Authors:  J Lindenbaum
Journal:  Blood       Date:  1983-04       Impact factor: 22.113

4.  Role of Helicobacter pylori infection in pernicious anaemia.

Authors:  B Annibale; E Lahner; C Bordi; G Martino; P Caruana; C Grossi; R Negrini; G Delle Fave
Journal:  Dig Liver Dis       Date:  2000-12       Impact factor: 4.088

Review 5.  Pernicious anemia: new insights from a gastroenterological point of view.

Authors:  Edith Lahner; Bruno Annibale
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

6.  Radioimmunoassay of plasmagastrin in pernicious anaemia, achlorhydria without pernicious anaemia, hypochlorhydria, and in controls.

Authors:  P C Ganguli; D R Cullen; W J Irvine
Journal:  Lancet       Date:  1971-01-23       Impact factor: 79.321

Review 7.  Malabsorption of food cobalamin.

Authors:  R Carmel
Journal:  Baillieres Clin Haematol       Date:  1995-09
  7 in total
  6 in total

Review 1.  Diagnosis and management of pernicious anemia.

Authors:  Bruno Annibale; Edith Lahner; Gianfranco Delle Fave
Journal:  Curr Gastroenterol Rep       Date:  2011-12

2.  Receiving a Diagnosis of Pernicious Anemia: Exploring Experiences of Relationships With Health Professionals.

Authors:  Catherine Heidi Seage; Emily Glover; Jenny Mercer
Journal:  J Patient Exp       Date:  2019-11-26

3.  The PTPN22 1858T allele but not variants in the proximal promoter region of IL-21 gene is associated with the susceptibility to type 1 diabetes and the presence of autoantibodies in a Brazilian cohort.

Authors:  D T O Mainardi-Novo; A S Santos; R T Fukui; M Gamberini; M R S Correia; M O Ruiz; C L P Mangueira; S R Matioli; D M Vasconcelos; M E R Silva
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

4.  Optimal management of pernicious anemia.

Authors:  Emmanuel Andres; Khalid Serraj
Journal:  J Blood Med       Date:  2012-09-10

5.  Poland syndrome associated with pernicious anemia and gastric dysplasia.

Authors:  Erman Aytaç; Ali Vedat Durgun; Deram Büyüktaş; Deram Büyüktaş; Sibel Erdamar; Seniz Ongören
Journal:  Turk J Haematol       Date:  2012-12-05       Impact factor: 1.831

6.  Prevalence of pernicious anemia in patients with macrocytic anemia and low serum B12.

Authors:  Abdulmanea Aa; Alsaeed Ah; Shaik Ap; AlGahtani Fh
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.